MARIE ROMMAGE: Open Payments
NPI 1851809131 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,676 in 25 payments from 8 companies in 2025. Trend: 2023 $782 · 2024 $767 · 2025 $1,676
Food & beverage: $1,676
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $785 |
| Alkermes, Inc. | 7 | $454 |
| Neurocrine BioSciences, Inc. | 3 | $179 |
| Janssen Pharmaceuticals, Inc | 1 | $133 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Lundbeck LLC | 1 | $26 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: COBENFY, LYBALVI, ARISTADA, INGREZZA, SPRAVATO, ABILIFY ASIMTUFII, REXULTI, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
